Literature DB >> 18077535

SPECT low-field MRI system for small-animal imaging.

Christian Goetz1, Elodie Breton, Philippe Choquet, Vincent Israel-Jost, André Constantinesco.   

Abstract

UNLABELLED: Localization of regions with increased uptake of radiotracer in small-animal SPECT is greatly facilitated when using coregistration with anatomic images of the same animal. As MRI has several advantages compared with CT (soft-tissue contrast and lack of ionizing radiation) we developed a SPECT/low-field MRI hybrid device for small-animal imaging.
METHODS: A small-animal single-pinhole gamma-camera (pinhole, 1.5 mm in diameter and 12 cm in focal length) adjacent to a dedicated low-field (0.1 T) small MR imager (imaging volume, 10 x 10 x 6 cm(3)) was used. The animal was placed in a warmed nonmagnetic polymethyl methacrylate imaging cell for MR acquisition, which was followed immediately by SPECT after translation of the imaging cell from one modality to the other. 3-Dimensional T1-weighted sequences were used for MRI. Phantom studies enabled verification of a low attenuation (10%) for (99m)Tc and (201)Tl and a very slight increase in Compton scattering due to the radiofrequency coil and polymethyl methacrylate imaging cell.
RESULTS: SPECT/MRI data acquisition and image coregistration of selected examples using different radiotracers for lungs, kidneys, and brain were obtained in 3 nude mice with isotropic spatial resolutions of 0.5 x 0.5 x 0.5 mm(3) for MRI and 1 x 1 x 1 mm(3) for SPECT. The total acquisition time for combined SPECT and MRI lasted 1 h 45 min.
CONCLUSION: A low-magnetic-field strength of 0.1 T is a simple and useful solution for a small-animal dual-imaging device combining pinhole SPECT with the adjacent MR imager.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077535     DOI: 10.2967/jnumed.107.044313

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  Pre-clinical PET/MR: technological advances and new perspectives in biomedical research.

Authors:  Hans F Wehrl; Martin S Judenhofer; Stefan Wiehr; Bernd J Pichler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

2.  Estimation of subject coregistration errors during multimodal preclinical imaging using separate instruments: origins and avoidance of artifacts.

Authors:  Jean-Philippe Dillenseger; Christian Goetz; Amira Sayeh; Chris Healy; Isabelle Duluc; Jean-Noël Freund; André Constantinesco; Gaëlle Aubertin-Kirch; Philippe Choquet
Journal:  J Med Imaging (Bellingham)       Date:  2017-08-22

Review 3.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

4.  A 20-channel receive-only mouse array coil for a 3 T clinical MRI system.

Authors:  Boris Keil; Graham C Wiggins; Christina Triantafyllou; Lawrence L Wald; Florian M Meise; Laura M Schreiber; Klaus J Klose; Johannes T Heverhagen
Journal:  Magn Reson Med       Date:  2011-03-23       Impact factor: 4.668

Review 5.  Application of Advanced Imaging Modalities in Veterinary Medicine: A Review.

Authors:  Dagmawi Yitbarek; Gashaw Getaneh Dagnaw
Journal:  Vet Med (Auckl)       Date:  2022-05-31

6.  Initial Investigation of preclinical integrated SPECT and MR imaging.

Authors:  Mark J Hamamura; Seunghoon Ha; Werner W Roeck; Douglas J Wagenaar; Dirk Meier; Bradley E Patt; Orhan Nalcioglu
Journal:  Technol Cancer Res Treat       Date:  2010-02

7.  Development of clinical simultaneous SPECT/MRI.

Authors:  Brian F Hutton; Michele Occhipinti; Andre Kuehne; Domokos Máthé; Noémi Kovács; Helmar Waiczies; Kjell Erlandsson; Debora Salvado; Marco Carminati; Giovanni L Montagnani; Susan C Short; Luisa Ottobrini; Pieter van Mullekom; Claudio Piemonte; Tamas Bukki; Zoltan Nyitrai; Zoltan Papp; Kalman Nagy; Thoralf Niendorf; Irene de Francesco; Carlo Fiorini
Journal:  Br J Radiol       Date:  2017-03-07       Impact factor: 3.039

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.